Results 31 to 40 of about 2,244 (195)

Comparing Torsemide with Furosemide: Finally a Mechanistic Approach that Says, "Enough Already". [PDF]

J Am Soc Nephrol
Al-Awqati Q.
europepmc   +3 more sources

ESTIMATING THE COMPARATIVE EFFECT OF LOOP DIURETICS USING TRADITIONAL PHARMACOEPIDEMIOLOGICAL AND PRECISION MEDICINE STATISTICAL LEARNING METHODS [PDF]

, 2022
Loop diuretics (e.g. furosemide, bumetanide, torsemide) are an important therapeutic option for reducing edema, particularly in patients with heart failure (HF). Some studies have examined the safety and effectiveness of furosemide compared to torsemide,
Virkud, Arti
core   +1 more source

Sodium and Fluid Excretion With Torsemide in Healthy Subjects is Limited by the Short Duration of Diuretic Action

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundLoop diuretics are highly natriuretic but their short duration of action permits postdiuretic sodium retention, which limits salt loss unless dietary salt is severely restricted. We tested the hypothesis that a more prolonged duration of action
Salim Shah, Bertram Pitt, D. Craig Brater, Peter U. Feig, Wen Shen, Fatima S. Khwaja, Christopher S. Wilcox   +6 more
doaj   +1 more source

Efficacy of oral torasemide in dogs with degenerative mitral valve disease and new onset congestive heart failure: The CARPODIEM study

Journal of Veterinary Internal Medicine, 2020
Background Torasemide is a potent loop diuretic with potential to treat congestive heart failure (CHF) in dogs. Objective Evaluate the efficacy and safety of torasemide compared to furosemide in dogs with first occurrence of CHF caused by degenerative ...
Beatrice Besche, Thomas Blondel, Emilie Guillot, Catherine Garelli‐Paar, Mark A. Oyama   +4 more
doaj   +1 more source

Co-Administration of Drugs and Parenteral Nutrition: In Vitro Compatibility Studies of Loop Diuretics for Safer Clinical Practice

Pharmaceutics, 2020
Parenteral nutrition (PN) admixtures are prone to interacting with drugs administered intravenously via a common catheter. This may cause a threat to a patient’s health and life.
Szymon Tomczak, Maciej Stawny, Anna Jelińska   +2 more
doaj   +1 more source

Minimal Change Disease in an Adult: A Case Report

Journal of Nepal Medical Association, 2022
Minimal change disease is an important cause of nephrotic syndrome in children, however, few cases are seen among adults. There is very little literature regarding the occurrence of minimal change disease in adults.
Shashank Neupane, Prasamsa Pudasaini, Anupam Sharma, Shriya Sharma, Aakriti Adhikari , Kumar Roka   +5 more
doaj   +1 more source

DESIGN AND EVALUATION OF TORSEMIDE CONTROLLED RELEASE MATRIX TABLETS [PDF]

, 2015
 Objective: The controlled release Torsemide matrix tablets were prepared using different natural polymers in various proportions as releaseretarding agents to control the torsemide release and to improve the patient compliance.Methods: Torsemide matrix
Velmurugan, Sellappan, Rao P, Veerabhadra, ASWANI MACHARLA   +2 more
core   +1 more source

Formulation and Evaluation of Torsemide Granules (Sustained Release) [PDF]

, 2019
The aim of study was to design development and optimize a controlled release system of Torsemide. to increase its bioavailability by increasing the residence time in the stomach without contact with the mucosa, and was achieved through the preparation of
Verma, Navneet Kumar, Singh, Satya Prakash   +1 more
core   +1 more source

Use of short‐acting vs. long‐acting loop diuretics after heart failure hospitalization

ESC Heart Failure, 2022
Aims Furosemide, a short‐acting loop diuretic (SD), is the dominant agent prescribed for heart failure (HF) in clinical practice. However, accumulating data suggests that long‐acting loop diuretics (LD), such as torsemide or azosemide, might have more ...
Shohei Imaeda, Yasuyuki Shiraishi, Shun Kohsaka, Nozomi Niimi, Ayumi Goda, Yuji Nagatomo, Makoto Takei, Mike Saji, Shintaro Nakano, Takashi Kohno, Keiichi Fukuda, Tsutomu Yoshikawa   +11 more
doaj   +1 more source

Antihypertensive Medications Use among Chronic Hemodialysis Patients Visiting the Outpatient Department of Nephrology of a Tertiary Care Centre: A Descriptive Cross-sectional Study

Journal of Nepal Medical Association, 2023
Introduction: Anti-hypertensive medications are prescribed for the management of high blood pressure which is the leading cause of mortality in chronic hemodialysis patients. The objective of our study was to find out the prevalence of anti-hypertensive
Lujaw Ratna Tuladhar, Diwakar Manandhar, Sanjida Ansari, Nabin Khadka, Deepak Regmi   +4 more
doaj   +1 more source